Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

ExpertiseUpdated on 18 May 2026

Blood-Brain Barrier in vitro to in vivo models

business developer BIOMED / academic liaison manager Health Campus Limburg DC at Hasselt University - Biomedical Research Institute

Diepenbeek, Belgium

About

▶ Test your neuro compound or cell therapy for targeted treatment in the CNS

▶ Perform functional testing of your compound or cell therapy for restoring impaired BBB

▶ Building on our vast expertise in BBB testing, immunology and neurosciences

The blood-brain barrier (BBB) establishes a physical barrier between the blood and the central nervous system (CNS). It prevents the ingress of small molecules and its integrity can be compromised by eg. inflammation in several conditions, such as Multiple Sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD),… With our validated models, compounds or cell therapies can be tested on their interaction with the BBB.

Similar opportunities